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From the Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida 32816

The transcription factor NF-B mediates the major inflammatory signal pathways and regulates the most inflammatory
gene expression (1). Excessive and prolonged activation of
NF-B can cause massive damage to host tissue and can result
in human inflammatory diseases such as atherosclerosis and
arthritis (2). Thus, the activation of NF-B must be terminated
through multiple mechanisms, including recruitment of transcriptional corepressors (3–5).
TTP2 is an RNA-binding protein required for the rapid degradation of mRNAs containing AU-rich elements (6). Targets
regulated by TTP include the mRNAs encoding TNF␣ (7),
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granulocyte-macrophage colony-stimulating factor (8), and
interleukin-2 (9), etc. Mice deficient in TTP develop an inflammatory syndrome characterized by cachexia, spontaneous
arthritis, dermatitis, and neutrophilia (10). The inflammatory
syndrome in TTP⫺/⫺ mice is caused mainly by overproduction
of TNF␣, as neutralizing antibodies reactive with TNF␣ prevent most of the inflammatory symptoms in TTP⫺/⫺ mice (10).
Overexpression of TNF␣ in TTP⫺/⫺ mice may be explained by
its prolonged mRNA half-life, but other mechanisms may also
exist. Accumulating evidence indicates that TTP may have
additional functions besides influencing cytokine mRNA stability. In Schizosaccharomyces pombe, a TTP-related protein is
required for effective transmission of a pheromone-induced
Ras/mitogen-activated protein kinase (MAPK) signal (11). In
addition, a nim/cdc25 mutant can be complemented by either
the Cdc2 kinase or a TTP/TIS11 gene, suggesting a cell cycle
effect (12). A TTP/TIS11-related protein in Saccharomyces cerevisiae is required for normal metabolism and retards cell
growth when overexpressed (13). TTP is induced during apoptosis in response to the breast cancer susceptibility protein
BRCA1 (14). Furthermore, continuous expression of TTP at
physiological levels causes apoptotic cell death (15, 16). These
observations indicate that TTP protein might influence regulatory pathways that regulate survival, differentiation, or proliferation. In a genome-wide analysis of TTP-affected glucocorticoid targets, the half-lives of many TTP target mRNAs were not
increased in TTP⫺/⫺ cells, suggesting a regulatory role for TTP
not limited to mRNA turnover (17). In addition, TTP is shuttled
between the cytoplasm and nucleus (18). It promotes mRNA
decay in the cytoplasm. However, what it does in the nucleus is
unknown.
We report here that TTP also negatively regulates NF-B
signaling at the transcriptional corepressor level. It suppresses
the transcriptional activity of p65/NF-B by recruiting HDACs
on the NF-B target gene promoters. These results suggest that
TTP may control the inflammatory response through multiple
mechanisms, including inhibition of transcription in the
nucleus and promotion of mRNA decay in the cytoplasm.

MATERIALS AND METHODS
Cells—Littermate wild-type and TTP⫺/⫺ day 14.5 embryos
were used to generate MEF cell lines 67⫹/⫹ and 66⫺/⫺, respectively (provided by Dr. Perry J. Blackshear, NIEHS, NIH,
Research Triangle Park, NC). Cells were grown as a monolayer
in Dulbecco’s modified Eagle’s medium (Invitrogen) containing
10% fetal bovine serum, 2 mM L-glutamine, and 100 units/ml
each penicillin and streptomycin. The mouse macrophage cell
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Tristetraprolin (TTP) is a CCCH zinc finger-containing protein that destabilizes mRNA by binding to an AU-rich element.
Mice deficient in TTP develop a severe inflammatory syndrome
mainly because of overproduction of tumor necrosis factor ␣.
We report here that TTP also negatively regulates NF-B signaling at the transcriptional corepressor level, by which it may
repress inflammatory gene transcription. TTP expression
inhibited NF-B-dependent transcription. However, overexpression of TTP did not affect reporter mRNA stability. Instead,
TTP functioned as a corepressor of p65/NF-B. In support of
this concept, we found that TTP physically interacted with the
p65 subunit of NF-B and was also associated with HDAC1, -3,
and -7 in vivo. Treatment with histone deacetylase inhibitors or
small interfering RNA induced HDAC1 or HDAC3 knockdown
completely or partly abolished the inhibitory activity of TTP on
NF-B reporter activation. Consistently, chromatin immunoprecipitation showed decreased recruitment of HDAC1 and
increased recruitment of CREB-binding protein on the Mcp-1
promoter in TTPⴚ/ⴚ cells compared with wild-type cells. Moreover, overexpression of TTP blocked CREB-binding protein-induced acetylation of p65/NF-B. Taken together, these data
suggest that TTP may also function in vivo as a modulator in
suppressing the transcriptional activity of NF-B.
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(345–551) were transformed into E. coli BL21 cells by the CaCl2
method. At A600 ⫽ 0.8, the cells were induced with isopropyl
␤-D-thiogalactopyranoside (0.2 mM final concentration) at
30 °C for 3 h and then lysed in buffer containing 25 mM TrisHCl (pH 7.4), 150 mM NaCl, 10% glycerol, 1 mM dithiothreitol,
protease inhibitor mixture (Complete Mini, Roche Applied Science), and 0.05% Triton X-100, followed by three 10-s pulses of
sonication. Glutathione-Sepharose CL-4B beads (GE Healthcare) were incubated with the lysates for 1 h. The beads containing the bound GST-p65 fusion protein or the bound GST
protein were pelleted and extensively washed with lysis buffer.
Protein contents were quantified against known amounts of
bovine serum albumin on Coomassie Brilliant Blue-stained
SDS-polyacrylamide gels. Equal quantities of GST-p65 fusion
protein or GST protein bound to the glutathione-Sepharose
CL-4B beads were separately added to the precleared TTP-HA
cell lysates and incubated overnight at 4 °C. The bound proteins
from the TTP-HA-expressing cell lysates (pulldown assays)
were pelleted with the beads at 2000 rpm in a microcentrifuge,
washed, and separated on SDS-polyacrylamide gels. The separated proteins were then analyzed by Western blotting with
anti-HA antibody to detect the pulled-down TTP-HA, followed
by Coomassie Brilliant Blue staining to confirm the presence of
GST protein or GST-p65 fusion protein in samples as
appropriate.
Chromatin Immunoprecipitation Assay—ChIP assay was
performed using the ChIP assay kit (Upstate Biotechnology)
according to the manufacturer’s instructions. The immunoprecipitation-enriched DNA was quantified by real-time PCR, and
the values were normalized by the input DNA. The primers
used to amplify the Mcp-1 promoter were 5⬘-CACCCCATTACATCTCTTCCCC-3⬘ and 5⬘-TGTTTCCCTCTCACTTCACTCTGTC-3⬘.
Statistics—Data are expressed as means ⫾ S.D. For comparison between two groups, the unpaired Student’s test was used.
For multiple comparisons, analysis of variance followed by the
unpaired Student’s test was used. A p value of ⬍0.05 was considered significant.

RESULTS
TTP Expression Inhibits TNF␣ Promoter Activity—TTP is the
prototype member of a CCCH zinc finger protein family, which
down-regulates expression of many inflammatory genes by
destabilizing their mRNAs. Recently, we identified the novel
CCCH zinc finger protein MCPIP1 (MCP-1-induced protein
1), which down-regulates cytokine-induced TNF␣ expression
by repressing its mRNA transcription but does not affect its
mRNA stability (19). In luciferase reporter experiments, TTP
was transfected to serve as a control. Surprisingly, we found
that overexpression of TTP strongly inhibited mouse TNF␣
promoter activity in a dose-dependent manner in both HEK293
and RAW264.7 cell lines (Fig. 1, A and B). Although TTP can
mediate mRNA stability, this is unlikely to explain the results in
Fig. 1 (A and B) because the mRNA transcribed from the
reporter construct lacked the AU-rich element associated with
TTP-mediated mRNA destabilization. Nevertheless, to exclude
this possibility, we determined the half-life of luciferase mRNA
under the influence of TTP. To accomplish this, HEK293 cells
VOLUME 284 • NUMBER 43 • OCTOBER 23, 2009
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line RAW264.7 and HEK293 cells were cultured as described
previously (19).
Plasmids—The TNF␣-Luc reporter construct was kindly
provided by Dr. Dmitry V. Kuprash (Russian Academy of Science) and was described previously (20). NF-B-TK-Luc was
purchased from Stratagene (La Jolla, CA). The pGL3-Control
vector was from Promega. HA-tagged TTP and TTP-C124R
expression plasmids were kindly provided by Dr. Perry J. Blackshear. The pGal4-p65-(270 –591) plasmid was kindly provided
by Dr. Brian P. Ashburner (University of Toledo). Gal4-TK-Luc
and pcDNA-p65 were described previously (19). pGST-p65(1–305), pGST-p65-(245–355), and pGST-p65-(345–551)
were gifts from Dr. David R. Jones (University of Virginia).
FLAG-HDAC1, FLAG-HDAC2, FLAG-HDAC3, and FLAGHDAC7 were kindly provided by Dr. Ronald M. Evans (Salk
Institute). CMX-CBP and CMX-SMRT expression plasmids
were provided by the laboratory of Dr. Mangelsdorf. CMVFLAG-KNP1 was generated in this laboratory.
Reagents—Antibodies against phospho-IKK␤ (Ser180), phospho-IB␣ (Ser32), acetyl-p65, HDAC1, HDAC3, CBP, and HA
tag were purchased from Cell Signaling Technology Inc. Antip65/NF-B and anti-TTP (G-20) antibodies and siRNAs for
TTP, HDAC1, and HDAC3 were from Santa Cruz Biotechnology. Anti-FLAG tag antibody, an anti-HA immunoprecipitation kit, LPS (Escherichia coli 026:B6-derived), human recombinant interferon-␥, IL-1␤, and TNF␣ were purchased from
Sigma. Anti-SMRT antibody was purchased from Abcam. Glutathione-Sepharose 4B was purchased from GE Healthcare.
Apicidin was purchased from BIOMOL.
Transfection—Transient transfection and luciferase assay
were performed as described previously (19).
Protein Isolation and Western Blotting—Protein isolation
and Western blotting were essentially performed as described
previously (19).
Co-immunoprecipitation—Co-immunoprecipitation assays
were performed by using an anti-HA immunoprecipitation kit
or a protein G immunoprecipitation kit (Sigma) following the
manufacturer’s instruction. Briefly, subconfluent HEK293 cells
on a 10-cm plate were transfected with 10 g of the indicated
combinations of expression vectors by the calcium phosphate
method. After 24 h, the transfected cells were left untreated or
treated with TNF␣ for 15 min. Cells were lysed in CelLytic M
cell lysis buffer with protease inhibitors and phosphatase inhibitors. Cell lysates were incubated with anti-HA beads overnight
at 4 °C. After extensive washing, immunoprecipitated proteins
were resolved by 6 –10% SDS-PAGE and analyzed by Western
blotting with anti-HA or anti-p65 antibodies. Membranes were
developed with enhanced chemiluminescence (Amersham Biosciences). For endogenous immunoprecipitations, RAW264.7
cells were treated with LPS (1 g/ml) for 0, 2, 4, and 8 h. The cell
lysates were incubated with anti-TTP polyclonal antibody or
rabbit anti-IgG as a control. The immune complexes were collected by incubation (2 h, 4 °C) with protein G-agarose (Sigma).
Western blotting for detection of endogenous TTP, p65, and
HDAC1 was performed with anti-TTP, anti-p65, and antiHDAC1 polyclonal antibodies, respectively.
GST Fusion Protein Pulldown Assay—Plasmids pGST,
pGST-p65-(1–305), pGST-p65-(245–355), and pGST-p65-
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phorbol 12-myristate 13-acetate-induced AP-1 reporter activation
(data not shown). As it was noted
previously that TTP overexpression
leads to nonspecific “squelching” of
reporter constructs (7), we tested
the effect of TTP on an SV40-driven
control reporter. The same concentrations of the TTP plasmid did not
affect SV40 promoter-mediated
gene expression. To further confirm
that the suppressive effect of TTP
on the NF-B reporter is specific
rather than caused by “promoter
squelching,” we tested the effect of
the unrelated protein FLAG-KNP1
on the NF-B reporter. As shown in
Fig. 2C, expression of TTP significantly inhibited TNF␣-induced
NF-B activation. However, expression of KNP1 did not affect NF-B
reporter activity at all. Expression of
both TTP and FLAG-KNP1 was
controlled by the cytomegalovirus
promoter. Their expression in the
transfected cells is shown in Fig. 2C
FIGURE 1. TTP expression inhibits TNF␣ promoter activity. A and B, HEK293 or RAW264.7 cells were cotrans- (lower panels). Interestingly, TTPfected with a luciferase reporter plasmid under the transcriptional control of the mouse TNF␣ promoter and C124R, the first zinc finger mutant
increasing amounts of TTP-HA (0, 25, 100, and 400 ng/well). After being quiescent for 24 h, cells were treated
with or without IL-1␤ (10 ng/ml) or LPS (0.1 g/ml) as shown and collected for analysis of reporter gene activity of TTP, also significantly repressed
24 h later. Data represent means ⫾ S.D. from three independent experiments. *, p ⬍ 0.05; **, p ⬍ 0.01 versus TNF␣-induced NF-B activation
IL-1␤ stimulation without the TTP-HA-transfected group. The gels under the graph in A are the protein levels of
but was less potent compared with
TTP-HA and actin in the transfected cell lysates detected by Western blotting. C, HEK293 cells were transiently
transfected with the pcDNA3.1 or pTTP-HA expression construct. After 24 h, the cells were quiescent for 18 h the wild-type TTP protein (Fig. 2C).
and then treated with IL-1␤ (10 ng/ml) for 8 h, and actinomycin D (10 g/ml) was added to stop transcription.
To further explore the role of
RNA was harvested after different time points as indicated. The luciferase (Luc.) mRNA level was examined by
endogenous
TTP in NF-B regulaNorthern blotting. D, the intensity of the bands in B was quantified using an AlphaImager 2200 system (Alpha
Innotech). The value of the 0 point was set as 100%, and the values of the other points were transformed tion, we transfected the NF-B
according to the 0 point. The data from three independent experiments were averaged and plotted.
reporter into TTP⫹/⫹ and TTP⫺/⫺
MEFs. 24 h later, the cells were stimwere transfected with the luciferase reporter driven by the ulated with LPS (0.1 g/ml) or IL-1␤ (10 ng/ml) for 24 h. The
TNF␣ promoter with or without the TTP plasmid and then basal reporter activity was increased by 7-fold in TTP⫺/⫺ MEFs
stimulated with IL-1␤ 24 h after transfection. After 8 h of stim- compared with TTP⫹/⫹ MEFs. LPS and IL-1␤ induced an
ulation, cells were treated with actinomycin D (10 g/ml), and ⬃2-fold increase in reporter activity in both TTP⫹/⫹ and
RNA was harvested at serial time points as indicated. Luciferase TTP⫺/⫺ MEFs (Fig. 2D). In addition, we observed the effect of
mRNA extracted from these samples was quantified by North- knockdown of TTP on NF-B-dependent gene expression by
ern blotting. As shown in Fig. 1 (C and D), TTP coexpression using siRNA. These experiments were performed in RAW264.7
did not influence the half-life of luciferase mRNA. These results cells transiently cotransfected with the NF-B reporter and
indicate that TTP may regulate TNF␣ expression at the level of siRNA for TTP or the scrambled control and stimulated with
transcription.
LPS (0.1 g/ml) for 24 h. As shown in Fig. 2E, LPS induced
TTP Inhibits NF-B-dependent Gene Activation—TNF␣ NF-B reporter activity by 6.3-fold in RAW264.7 cells transproduction is coordinately regulated by NF-B-, AP-1 (activa- fected with scrambled control siRNA. The induction of NF-B
tor protein 1)-, and STAT-mediated signal pathways (20). To reporter activity was further increased by 11.2-fold in cells
further understand how TTP represses TNF␣ transcription, we transfected with TTP siRNA. Western blotting demontested whether TTP affects the activation of NF-B-, AP-1-, strated that the siRNA effectively reduced TTP protein levels
and STAT-mediated signaling by luciferase assays. As shown in by ⬎60% relative to the control, whereas the internal control
Fig. 2A, TTP overexpression significantly inhibited the basal ␤-actin was not affected. Taken together, these results sugand stimulus-induced NF-B activation in a concentration-de- gest that TTP feedback controls LPS-induced NF-B
pendent manner. TTP did not affect the basal reporter activity activation.
of STAT, but a high level of TTP transfection did reduce interTTP Represses p65/NF-B Transactivation—To further
feron-␥- and LPS-induced STAT reporter activation as well as examine how TTP regulates NF-B signaling, we investigated
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phosphorylation and degradation.
In addition, the overall protein concentration of NF-B p65 was not
affected by overexpression of TTP.
To determine whether TTP
represses p65/NF-B transactivation activity, NF-B-TK-Luc was
cotransfected with the expression
construct p65 and increasing
amounts of HA-TTP or SMRT (a
well known corepressor of NF-B
and other transcription factors) into
HEK293 cells. As shown in Fig. 3B,
expression of p65 activated NF-Bdependent reporter expression by
32.8-fold. Expression of TTP repressed this activation in a concentration-dependent manner. Used as
a positive control, SMRT expression
also markedly repressed p65-induced NF-B reporter activation.
Overexpression of TTP and SMRT
in the transfected cells is shown in
Fig. 3B (lower panels).
p65/NF-B contains a TAD and a
Rel homology domain. To further
confirm that TTP affects the transactivation activity but not activation
and DNA binding of p65, we
cotransfected the Gal4 reporter
containing five copies of the Gal4binding site (Gal4-TK-Luc) with the
Gal4-p65(TAD) fusion construct
and increasing amounts of TTPHA. As shown in Fig. 3C, TTP also
dramatically suppressed Gal4p65(TAD)-activated reporter expression. These results suggest that
TTP may directly repress the p65/
NF-B transactivation domain.
FIGURE 2. TTP represses NF-B-dependent gene expression. A and B, HEK293 cells were cotransfected with
TTP Physically Interacts with
the NF-B-TK-Luc (A) or pGL3-Control (B) vector as indicated with increasing amounts of pTTP-HA (0, 25, 100,
p65—Next,
we investigated whethand 400 ng/well) by the calcium phosphate method. After being quiescent for 16 h, cells were treated with or
without TNF␣ (10 ng/ml) (A) and collected for analysis of reporter gene activity 24 h later. *, p ⬍ 0.01 versus er TTP physically interacts with the
stimulation without the TTP-HA-transfected group. C, HEK293 cells were cotransfected with NF-B-TK-Luc with p65 subunit of NF-B. HEK293 cells
or without expression plasmids as indicated and subjected to the same treatment as described above. The
proper protein expression is shown in the lower panels. D, NF-B-Luc was transfected into TTP⫹/⫹ or TTP⫺/⫺ were transfected with p65 and
MEFs by FuGENE 6. 24 h later, the cells were stimulated with LPS (0.1 g/ml) or IL-1␤ (10 ng/ml) for another 24 h. pTTP-HA expression plasmids.
The luciferase (Luc.) activity was measured and normalized by ␤-galactosidase activity. The number on each bar
24 h post-transfection, the cells
represents -fold over the untreated group in TTP⫹/⫹ cells. E, scrambled control (siControl) or TTP (siTTP) siRNA
was cotransfected with NF-B-Luc into RAW264.7 cells by electroporation (Amaxa). 24 h later, the cells were were untreated or treated with
quiescent for 12 h and then stimulated with LPS (0.1 g/ml) for another 24 h. The luciferase activity was TNF␣ for 30 min. Protein extracts
measured and normalized by ␤-galactosidase activity. The TTP and ␤-actin protein levels in the transfected
were prepared and subjected to
cells were analyzed by Western blotting and are shown in the lower panels.
immunoprecipitation with anti-HA
the effect of TTP on IKK␤ and IB␣ phosphorylation. The beads followed by immunoblotting with both anti-p65 and
transfected HEK293 cells were quiescent and then stimulated anti-HA antibodies. As shown in Fig. 4A, TTP physically interwith TNF␣ for various times as indicated. The whole cell lysates acted with p65 in untreated cells. TNF␣ treatment reduced
were subjected to Western blot analysis using anti-phospho- TTP binding to p65. To further test whether endogenous TTP
IKK␤ and anti-phospho-IB␣ antibodies. As shown in Fig. 3A, protein is also associated with endogenous p65, RAW264.7
there were no differences between TTP-overexpressing and cells were treated with LPS (0.1 g/ml) for 0, 2, 4, and 8 h. The
normal cells in the extent of TNF␣-induced IKK␤ and IB␣ cell lysates were immunoprecipitated by anti-TTP antibody fol-
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lowed by protein G purification. Both whole cell extracts and
immunoprecipitates were subjected to Western blot analysis
with anti-TTP and anti-p65 antibodies. As shown in Fig. 4B,
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FIGURE 3. TTP represses transactivation of p65. A, HEK293 cells were transfected with pcDNA3.1 or pTTP-HA. After 24 h, the transfected cells were quiescent for 16 h and then stimulated with TNF␣ (10 ng/ml) for the indicated times.
Whole cell extracts were isolated and subjected to Western blot analysis using
anti-phospho-IKK␤, anti-phospho-IB␣, anti-p65, or anti-HA antibody as indicated. B and C, HEK293 cells were transfected with NF-B-TK-Luc, p65, and
increasing amounts of pTTP-HA as indicated or SMRT (B) or with Gal4-TK-Luc with
an expression construct encoding the Gal4-p65(TAD) fusion protein and increasing amounts of pTTP-HA (C) as indicated. 36 h later, the cells were collected for
analysis of reporter gene activity and protein expression. *, p ⬍ 0.01 versus stimulation without the TTP-HA-transfected group. Luc., luciferase.

endogenous TTP associated with p65 peaked at 4 h after LPS
stimulation but declined at 8 h after LPS stimulation. Consistent with previous reports, TTP protein was significantly
induced by LPS (22). Taken together, these results suggest that
TTP can physically interact with p65, which is dynamically regulated by TNF␣ and LPS.
To examine the TTP interaction region of p65, HEK293
lysates overexpressing TTP-HA were incubated with GST,
GST-p65-(1–305), GST-p65-(245–355), or GST-p65-(345–
551); washed; and separated on SDS-polyacrylamide gels.
The separated proteins were then analyzed by Western blotting with anti-HA antibody to detect the pulled-down
TTP-HA followed by Coomassie Brilliant Blue staining to
confirm the presence of GST protein or GST-p65 fusion protein in samples as appropriate. As shown in Fig. 4C, TTP was
found to interact with GST-p65-(245–355) and GST-p65(345–551) but not GST-p65-(1–305). Thus, the C-terminal
region (positions 345–355) of p65 may be responsible for
binding to TTP.
Involvement of HDACs in the TTP-mediated Inhibitory Effect
on NF-B—As documented, the transactivation function of
NF-B is regulated through interaction with HDAC corepressor proteins (23). By analogy, TTP may also associate with
HDACs. To test this possibility, FLAG-tagged HDAC1,
HDAC2, HDAC3, and HDAC7 were cotransfected with HAtagged TTP into HEK293 cells. Cell lysates of the transfected
cells were immunoprecipitated with HA-specific antibody and
subjected to Western blot analysis for HDACs and TTP. As
shown in Fig. 5A, HDAC1, HDAC3, and HDAC7 were readily
co-immunoprecipitated with TTP. HDAC2 was not found to be
immunoprecipitated with TTP, which may be due to the low
expression of HDAC2 in whole cell extracts (Fig. 1A). The
interaction of endogenous HDACs with endogenous TTP was
also determined by co-immunoprecipitation. As shown in Fig.
5B, HDAC1 was specifically precipitated by anti-TTP antibody
but not by IgG or anti-SRA antibody in LPS-treated RAW264.7
cell extracts.
To determine whether TTP represses the transcriptional
activity of NF-B through HDACs, apicidin, a potent tetrapeptide HDAC inhibitor, was used to treat the transfected HEK293
cells. As shown in Fig. 5C, TNF␣ induced NF-B promoter
activation by 23-fold. Overexpression of TTP repressed its
activity to 7.5-fold. Interestingly, the inhibitory activity of TTP
on NF-B-mediated gene activation was completely abolished
in the presence of 500 nM apicidin. Thus, the inhibitory activity
of TTP on NF-B is mediated by HDAC activity. To further test
whether endogenous HDAC1 and HDAC3 mediate the inhibitory effect of TTP on NF-B, HEK293 cells were cotransfected
with control, HDAC1, or HDAC3 siRNA and TTP-HA and the
NF-B reporter. 24 h after transfection, the cells were treated
with TNF␣ for another 24 h. As shown in Fig. 5D, siRNA-mediated knockdown of HDAC1 or HDAC3 partly rescued the
effect of TTP on NF-B reporter activation. However, knockdown of both HDAC1 and HDAC3 completely rescued the
effect of TTP on NF-B activation, suggesting that both
HDAC1 and HDAC3 are involved in the TTP-mediated inhibitory effect on NF-B. Western blotting demonstrated that the
specific siRNAs effectively reduced the protein expression of
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this work, we have provided evidence that TTP also negatively regulates NF-B signaling in an HDACdependent manner. Using reporter
assays, we have shown that TTP
inhibits NF-B-mediated gene activation and that such an inhibitory
activity of TTP can be overcome by
suppressing HDAC activity or
expression. By in vivo co-immunoprecipitation and GST pulldown,
TTP was found to physically interact with the p65 subunit of NF-B
and to associate with HDAC1,
HDAC3, and HDAC7. Consistently,
TTP did not interfere with NF-B
signaling activation. Instead, TTP
FIGURE 4. TTP physically interacts with p65. A, HEK293 cells were transiently cotransfected with p65 with or diminished p65 acetylation. Furwithout the pTTP-HA expression plasmid. The transfected cells were stimulated with or without TNF␣ for 30
min. The whole cell lysates (WCE) were subjected to co-immunoprecipitation (IP) with anti-HA antibody fol- thermore, knockdown of TTP
lowed by Western blotting with anti-p65 or anti-HA antibody. The same lysates were subjected to SDS-PAGE enhanced
LPS-induced NF-B
and probed with anti-p65 or anti-HA antibody for proper protein expression. B, RAW264.7 cells were treated reporter activation, which is conwith LPS (0.1 g/ml) for 0, 2, 4, and 8 h. The cell extracts were subjected to immunoprecipitation with anti-TTP
antibody. Both whole cell extracts and immunoprecipitates were analyzed by Western blotting with anti-TTP sistent with increased CBP recruitand p65 antibodies. C, HEK293 cells were transfected with the pTTP-HA plasmid. After 24 h of transfection, the ment and decreased HDAC1
cells were treated with TNF␣ for 30 min. Aliquots of cell lysates were subjected to purification with glutathioneNF-B target
Sepharose beads already bound to GST, GST-p65-(1–305), GST-p65-(245–355), or GST-p65-(345–551). Proteins recruitment on the
⫺/⫺
promoter
in
TTP
cells. Comco-precipitated with GST beads were analyzed by Western blotting with anti-HA antibody. Whole cell extracts
were also analyzed by Western blot analysis with anti-HA antibody to monitor the expression of transfected bined with many other reports,
DNA. Coomassie (Comas.) Brilliant Blue stain showed the expression of GST and GST fusion proteins.
these results suggest that TTP may
critically regulate inflammatory
HDAC1 and HDAC3 by ⬎80% relative to control siRNA (Fig. gene expression through multiple mechanisms, including
5D, lower panel).
mRNA transcription and decay. However, the precise mechaIt is well known that acetylation of p65 by CBP/p300 is associ- nisms by which TTP represses mRNA transcription are not
ated with increased transcription without altering its binding to completely understood. Our studies suggest that TTP exerts
DNA (24). To further explore how TTP represses p65 transactiva- this effect at least partly through recruitment of HDACs to the
tion activity, we observed the effect of TTP expression on CBP- target promoter and diminishment of p65 acetylation. Howinduced acetylation of p65. As shown in Fig. 5E, cotransfection CBP ever, other mechanisms may also exist.
induced p65 acetylation. Overexpression of TTP completely abolConsistent with previously reports, there is low level of TTP
ished CBP-induced acetylation of p65. The results further support protein in resting RAW264.7 cells. LPS treatment caused a
that TTP may function as a transcriptional corepressor of p65 by marked increase in TTP protein. However, the pattern of p65
recruiting HDACs and diminishing p65 acetylation.
co-immunoprecipitation with TTP did not follow the pattern of
Absence of TTP Decreases HDAC1 but Increases CBP Recruit- TTP accumulation (Fig. 4B). It has been reported that LPS regment to the Mcp-1 Promoter—It has been reported that HDACs ulates TTP at both the transcriptional and post-transcriptional
and CBP are dynamically recruited to the NF-B target pro- levels. LPS-activated signaling pathways can dramatically
moter to precisely control gene expression. To further examine induce TTP expression, which could also induce phosphorylathe influence of endogenous TTP on the recruitment of tion of TTP (25). It was observed previously that p38-mediated
HDAC1 and CBP to the Mcp-1 promoter, we performed ChIP phosphorylation of TTP can shuttle TTP from the nucleus to
assay in TNF␣-treated TTP⫹/⫹ and TTP⫺/⫺ MEFs with anti- the cytoplasm and inhibit TTP binding to mRNA (26, 27). Our
HDAC1 and anti-CBP antibodies (Fig. 6). Consistent with the results suggest that LPS stimulates the binding of TTP to p65 at
results above, HDAC1 recruitment was significantly decreased an early time point (4 h) by induction of TTP expression and
in TTP⫺/⫺ MEFs compared with TTP⫹/⫹ MEFs. In contrast, prevents TTP interaction with p65 at a late time point (8 h) by
CBP recruitment was increased in TTP⫺/⫺ MEFs. As noted, the phosphorylation. This may also explain why TNF␣ treatment
absence of TTP did not affect the binding of p65 to the Mcp-1 reduced TTP interaction with p65 in the overexpressing cell
promoter. TTP recruitment on the Mcp-1 promoter was line (Fig. 4A). Interestingly, Zhu et al. (28) also observed that
induced by TNF␣ in TTP⫹/⫹ cells. As expected, no TTP p38-mediated TTP phosphorylation can release the suppresrecruitment was detected in TTP⫺/⫺ cells.
sive effect of TTP on TNF␣ transcription.
Our results suggest that TTP may also negatively regulate
DISCUSSION
AP-1- and STAT-mediated signaling pathways, as overexTTP is a tandem CCCH zinc finger protein that was charac- pression of TTP also repressed AP-1 and STAT reporter
terized as a destabilizing factor of inflammatory mRNAs (6). In activity (data not shown). However, there is no direct asso-
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One may ask whether the inhibitory effect of TTP on NF-B signaling is dependent on its RNA-destabilizing activity. We observed that
the first zinc finger mutant of TTP
also significantly suppressed NF-B
activation with less potency compared with the wild-type TTP protein. Because any zinc finger mutation of TTP protein completely
loses its RNA-binding activity (29),
our data suggest that the effect of
TTP on NF-B signaling may be
independent of its RNA-destabilizing activity but that its two zinc fingers may be required for transcription repression.
As reported previously, expression of TTP not only causes apoptotic cell death but also sensitizes cells
to induction of apoptosis by TNF␣
(15, 16). However, the molecular
mechanisms underlying these
events are not clear. It was well
established that maturing activated
monocytes face a choice between
NF-B-dependent survival and
differentiation and death by
TNF␣-induced apoptosis. Our
results suggest that overexpression of TTP may promote TNF␣induced apoptosis through repression of NF-B signaling.
At least 55 CCCH zinc finger
genes exist in the human genome
(30). Although most of the CCCH
proteins have been less characterized, most of the characterized
CCCH proteins are RNA-binding
proteins and regulate RNA metaboFIGURE 5. Involvement of HDACs in the TTP-mediated inhibitory effect on NF-B. A, HEK293 cells were
cotransfected with pTTP-HA and the FLAG-HDAC1, FLAG-HDAC2, FLAG-HDAC3, or FLAG-HDAC7 expression lism, including mRNA maturation,
plasmid. After 24 h of transfection, the whole cell lysates (WCE) were subjected to co-immunoprecipitation (IP) export, modification, and turnover
with anti-HA antibody followed by Western blotting (immunoblotting (IB)) with anti-FLAG or anti-HA antibody
as indicated. The same lysates were subjected to SDS-PAGE and probed with anti-FLAG or anti-HA antibody for (30). However, there are also some
proper protein expression. B, RAW264.7 cells were treated with LPS for 8 h. The cell extracts were subjected to CCCH proteins that regulate
immunoprecipitation by anti-TTP antibody, no specific IgG, or an unrelated antibody followed by Western blot mRNA transcription. For instance,
analysis with anti-TTP or HDAC1 antibody. The HDAC1 protein level in whole cell extracts was also probed by
anti-HDAC1 antibody. C, HEK293 cells were cotransfected with NF-B-TK-Luc and TTP-HA or the empty vector PIE-1 is a Caenorhabditis elegans
as indicated. The transfected cells were treated with or without HDAC inhibitor (apicidin at 0.1, 0.2, and 0.5 M) protein that contains two central
for 2 h and then stimulated with TNF␣ (10 ng/ml) for 24 h. Cells were collected for analysis of reporter gene CCCH zinc fingers. PIE-1 can funcactivity. The data are from three independent experiments (means ⫾ S.D.). *, p ⬍ 0.01 versus TTP-HA-transfected without the apicidin treatment group. D, HEK293 cells were transfected with scrambled control siRNA tion as a transcription repressor by
(siControl), HDAC1 siRNA (siHDAC1), or HDAC3 siRNA (siHDAC3) together with NF-B-Luc and the TTP-HA targeting to the basic transcripplasmid as indicated. 24 h later, the cells were quiescent for 12 h and then stimulated with TNF␣ for 24 h. The
reporter activity was analyzed. The HDAC1 and HDAC3 protein levels in the cell lysates were detected by tional machinery (31). Recently, we
Western blot analysis. *, p ⬍ 0.01 versus the scrambled control siRNA- and TTP-HA-transfected group. E, HEK293 identified the novel CCCH protein
cells were cotransfected with p65, CBP, and pTTP-HA as indicated. Cell lysates were extracted and analyzed by MCPIP1, which also represses
Western blotting with anti-acetyl-p65, anti-p65, and anti-HA antibodies.
TNF␣ transcription but does not
affect its mRNA stability (19). Actuciation of TTP with c-Fos/c-Jun or STAT1, suggesting that ally, TTP was also reported to interfere with the transcriptional
TTP may repress AP-1- and STAT-mediated signaling path- activity of Tax by directly interacting with Tax protein (32). Zhu
et al. (28) also observed that TTP can inhibit TNF␣ and IL-8
ways through different mechanisms.
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